Mentor: J. Andrew Jones, Ph.D. Psychedelic drugs have garnered much clinical attention for their promising therapeutic potential in the treatment of mental health conditions. However, the presence of ...
Contract to advance the research and development of new and innovative treatments for substance use disorders and mental health conditions ROUND ROCK, Texas, March 25, 2025 /PRNewswire/ -- Benuvia ...
The DEA has forwarded a petition to change the federal regulatory classification for psilocybin, the psychedelic compound found in "magic mushrooms," to HHS for a medical and scientific review. The ...
TORONTO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (MSSTF) (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery company ...
New Mexico’s Medical Psilocybin Act signals more than therapeutic access. It reflects a policy evolution, one where lawmakers, not just voters, are beginning to treat psychedelic medicine as a ...
“We are in the middle of a rapidly evolving cultural, media, and legal landscape when it comes to psychedelics,” says Nora D. Volkow, M.D., director of the National Institute on Drug Abuse (NIDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback